- Home
- CWK vs CPRX Comparison
CWK vs CPRX Comparison
Compare CWK & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWK
- CPRX
- Stock Information
- Founded
- CWK 1784
- CPRX 2002
- Country
- CWK United States
- CPRX United States
- Employees
- CWK N/A
- CPRX N/A
- Industry
- CWK Real Estate
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- CWK Finance
- CPRX Health Care
- Exchange
- CWK Nasdaq
- CPRX Nasdaq
- Market Cap
- CWK 2.7B
- CPRX 2.9B
- IPO Year
- CWK 2018
- CPRX 2006
- Fundamental
- Price
- CWK $11.71
- CPRX $21.81
- Analyst Decision
- CWK Hold
- CPRX Strong Buy
- Analyst Count
- CWK 7
- CPRX 6
- Target Price
- CWK $13.43
- CPRX $32.83
- AVG Volume (30 Days)
- CWK 2.0M
- CPRX 1.4M
- Earning Date
- CWK 07-28-2025
- CPRX 08-06-2025
- Dividend Yield
- CWK N/A
- CPRX N/A
- EPS Growth
- CWK 1337.16
- CPRX 178.13
- EPS
- CWK 0.69
- CPRX 1.57
- Revenue
- CWK $9,546,300,000.00
- CPRX $534,645,999.00
- Revenue This Year
- CWK $5.77
- CPRX $16.37
- Revenue Next Year
- CWK $5.65
- CPRX $8.80
- P/E Ratio
- CWK $17.00
- CPRX $13.93
- Revenue Growth
- CWK 1.24
- CPRX 29.97
- 52 Week Low
- CWK $7.64
- CPRX $15.34
- 52 Week High
- CWK $16.11
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- CWK 63.15
- CPRX 42.36
- Support Level
- CWK $11.26
- CPRX $20.62
- Resistance Level
- CWK $11.90
- CPRX $22.06
- Average True Range (ATR)
- CWK 0.37
- CPRX 0.66
- MACD
- CWK 0.04
- CPRX 0.03
- Stochastic Oscillator
- CWK 87.25
- CPRX 56.67
About CWK Cushman & Wakefield plc
Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such valuation, project management, and facilities management.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).